Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Condition:   Solid Tumors
Intervention:   Drug: RMC-4630
Sponsors:   Revolution Medicines, Inc.;   Sanofi
Not yet recruiting

https://ift.tt/2MCFeXO